(Press-News.org) Quebec City, June 20, 2013—Université Laval researchers have developed a highly effective method for converting CO2 into methanol, which can be used as a low-emissions fuel for vehicles. The team led by Professor Frédéric-Georges Fontaine presents the details of this discovery in the latest issue of the Journal of the American Chemical Society.
Researchers have been looking for a way to convert carbon dioxide into methanol in a single step using energy-efficient processes for years. "In the presence of oxygen, methanol combustion produces CO2 and water," explained Professor Fontaine. "Chemists are looking for catalysts that would yield the opposite reaction. That would allow us to slash greenhouse gas emissions by synthesizing a fuel that would reduce our dependence on fossil fuels."
The catalyst developed by Frédéric-Georges Fontaine and his team is made of two chemical groups. The first is borane, a compound of boron, carbon, and hydrogen. The second, phosphine, is made up of phosphorus, carbon, and hydrogen. "Unlike most catalysts developed thus far to convert CO2 into methanol, ours contains no metal, which reduces both the costs and toxic hazard of the catalyst," added the chemistry professor at the Faculty of Science and Engineering.
CO2 to methanol catalysis requires a source of hydrogen and chemical energy. The researchers had the idea of using a compound called hydroborane (BH3), and the results have been spectacular. The reaction achieved is two times more effective than the best catalyst known—and it produces little waste. What makes the discovery even more compelling is the fact that the chemical reaction does not damage the catalyst, which can be reactivated by adding new substrate.
The only downside of the operation is the price tag. "Our approach to creating methanol is highly effective from a chemistry standpoint, but for now the process is expensive," explained Professor Fontaine. "It takes a lot of energy to synthesize hydroborane, which makes it more expensive than methanol. We are working on ways to make the process more profitable by optimizing the reaction and exploring other hydrogen sources."
###
In addition to Frédéric-Georges Fontaine, the study's coauthors are: Marc-André Courtemanche and Marc-André Légaré (Université Laval); Laurent Maron (Université de Toulouse).
Information:
Frédéric-Georges Fontaine
Department of Chemistry
Faculty of Science and Engineering
Université Laval
418-656-5140
frederic.fontaine@chm.ulaval.ca
Too green to be true? Researchers develop highly effective method for converting CO2 into methanol
2013-06-20
ELSE PRESS RELEASES FROM THIS DATE:
American Chemical Society global program tackles safe drinking water in Colombia
2013-06-20
The Global Innovation Imperatives (Gii) program, administered by the American Chemical Society (ACS) Office of International Activities, today issued a white paper outlining possible solutions for increasing access to safe drinking water in the rural areas of the world. Although focused on the community of Chocontá, in Colombia, the suggested solutions have broader application.
Chocontá residents rely on rural aqueducts for their water, but supplies are vulnerable to pollution from nearby agriculture and largely go untreated. City officials asked ACS, the world's largest ...
'Forrest Gump' mice show too much of a good thing, can be bad
2013-06-20
VIDEO:
This video shows a control mouse doing a task to test cognitive skills. The mouse must start the test, then scan and touch the screen at the spot where...
Click here for more information.
A line of genetically modified mice that Western University scientists call "Forrest Gump" because, like the movie character, they can run far but they aren't smart, is furthering the understanding of a key neurotransmitter called acetylcholine (ACh). Marco Prado and his team at Robarts ...
Rhode Island Hospital reduces incidence of hospital-associated C. difficile by 70 percent
2013-06-20
PROVIDENCE, R.I. – Rhode Island Hospital has reduced the incidence of hospital-associated Clostridium difficile (C. difficile) infections by 70 percent and reduced annual associated mortality in patients with hospital-associated C. difficile by 64 percent through successive implementation of five rigorous interventions , as reported in the July 2013 issue of The Joint Commission Journal on Quality and Patient Safety.
Clostridium difficile is a toxin-producing bacterium that lives in the colon. A major cause of morbidity and mortality in the U.S., it can cause life-threatening ...
Virus combination effective against deadly brain tumor, Moffitt Cancer Center study shows
2013-06-20
A combination of the myxoma virus and the immune suppressant rapamycin can kill glioblastoma multiforme, the most common and deadliest malignant brain tumor, according to Moffitt Cancer Center research. Peter A. Forsyth, M.D., of Moffitt's Neuro-Oncology Program, says the combination has been shown to infect and kill both brain cancer stem cells and differentiated compartments of glioblastoma multiforme.
The finding means that barriers to treating the disease, such as resistance to the drug temozolomide, may be overcome. The study, by Forsyth and colleagues in Canada, ...
Making a beeline for the nectar
2013-06-20
Bumblebees searching for nectar go for signposts on flowers rather than the bull's eye. A new study, by Levente Orbán and Catherine Plowright from the University of Ottawa in Canada, shows that the markings at the center of a flower are not as important as the markings that will direct the bees to the center. The work is published online in Springer's journal, Naturwissenschaften - The Science of Nature.
The first time bees go out looking for nectar, which visual stimuli do they use to identify that first flower that will provide them with the reward they are looking ...
Scientists design a potential drug compound that attacks Parkinson's disease on 2 fronts
2013-06-20
JUPITER, FL-- Scientists from the Florida campus of The Scripps Research Institute (TSRI) have found a compound that could counter Parkinson's disease in two ways at once.
In a new study published recently online ahead of print by the journal ACS Chemical Biology, the scientists describe a "dual inhibitor"- two compounds in a single molecule-- that attacks a pair of proteins closely associated with development of Parkinson's disease.
"In general, these two enzymes amplify the effect of each other," said team leader Phil LoGrasso, a TSRI professor who has been a pioneer ...
Total amount of exercise important, not frequency, research shows
2013-06-20
A new study by Queen's University researchers has determined that adults who accumulated 150 minutes of exercise on a few days of the week were not any less healthy than adults who exercised more frequently throughout the week.
Ian Janssen and his graduate student Janine Clarke studied 2,324 adults from across Canada to determine whether the frequency of physical activity throughout the week is associated with risk factors for diabetes, heart disease and stroke.
"The findings indicate that it does not matter how adults choose to accumulate their 150 weekly minutes of ...
Goal of identifying nearly all genetic causes of deafness is within reach
2013-06-20
New Rochelle, NY, June 20, 2013—At least half of all cases of deafness that develop from birth through infancy in developed countries have a genetic basis, as do many cases of later onset progressive hearing loss. To date, at least 1,000 mutations occurring in 64 genes in the human genome have been linked to hearing loss. Next-generation DNA sequencing technologies are enabling the identification of these deafness-causing genetic variants, as described in a Review article in Genetic Testing and Molecular Biomarkers, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. ...
African-Americans on Medicaid are far less likely to receive living kidney transplants
2013-06-20
WINSTON-SALEM, N.C. – June 20, 2013 – African-Americans with Medicaid as their primary insurance were less likely to receive a living kidney transplant (LKT) than patients with private insurance, according to a new study by researchers at Wake Forest Baptist Medical Center.
The study is published on the Early View online edition of Clinical Transplantation.
"Living kidney transplantation is the optimal treatment for patients with end-stage renal disease, offering the best quality of life and longest survival," said Amber Reeves-Daniel, D.O., assistant professor of nephrology ...
Particle accelerator that can fit on a tabletop opens new chapter for science research
2013-06-20
AUSTIN, Texas — Physicists at The University of Texas at Austin have built a tabletop particle accelerator that can generate energies and speeds previously reached only by major facilities that are hundreds of meters long and cost hundreds of millions of dollars to build.
"We have accelerated about half a billion electrons to 2 gigaelectronvolts over a distance of about 1 inch," said Mike Downer, professor of physics in the College of Natural Sciences. "Until now that degree of energy and focus has required a conventional accelerator that stretches more than the length ...